2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories

Jump to: View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z

Nation-wide Slovak epidemiological study of movement disorders in Roma population: protocol and initial results

M. Skorvanek, A. Belak, J. Necpal, M. Ferenc, M. Giertlova, L. Gurcik, V. Han, S. Jaselska, G. Kalafusova, M. Krauz, K. Kulcsarova, A. Lackova, J. Mankos, Z. Matiskova, S. Orkuty, M. Ostrozovicova, J. Papikova, O. Shabatiuk, L. Trckova, D. Fricova (Kosice, Slovakia)
Nationwide Prevalence of Parkinson’s Disease in Slovakia: A Municipality-Level Analysis

M. Skorvanek, Z. Kosutzka, I. Berta (Košice, Slovakia)
Natural History of Sialidosis Type I: A Prospective Longitudinal Follow-Up Study of Clinical and Electrophysiological Markers

BY. Gu, YC. Kuo, HW. Hsueh, SP. Fan, CW. Lin, CY. Chien, TK. Lin, MY. Lan, YY. Chang, NC. Lee, YH. Chien, WL. Hwu, CH. Lin (Taipei, Taiwan)
Network determinants of stimulation-induced speech impairment after subthalamic DBS in Parkinson’s disease

M. Sousa, A. Jorge, P. Krýže, V. Illner, M. Castelli, D. Amstutz, K. Petermann, T. Khoa Nguyen, C. Pollo, J. Waskönig, L. Lachenmayer, I. Debove, G. Tinkhauser, S. Paschen, G. Kägi, T. Nef, G. Deuschl, A. Horn, J. Rusz, P. Krack (Bern, Switzerland)
Neural Control of Real-Time Walking in people with Parkinson’s disease

H. Sigurdsson, M. Firbank, P. Brown, C. Craig, J. Anton-Rodriguez, R. Maxwell, G. Petrides, S. Bhattacharjee, M. Bicer, S. Wallace, A. Watkins, N. Ray, N. Pavese, D. Brooks, M. Silverdale, L. Rochester, L. Alcock (San Joan de Alicante, Spain)
Neural Mechanisms of Motor Dysfunction in Idiopathic REM Sleep Behavior Disorder: An rs-fMRI Study Based on the Purdue Pegboard Test

QH. Zhang, H. Zhang, Y. Li, YK. Wang, Y. Yuan, W. Mao, P. Chan (Beijing, China)
Neural Network Reorganization Mediates the Analgesic Effects of Repetitive Transcranial Magnetic Stimulation in Parkinson’s Disease

C. Mao, M. Liu, Y. Luo, Y. Zhang, E. Wang, X. Cheng, J. Zhang, F. Wang, C. Liu (Suzhou, China)
Neurofilament Light Chain as a Prognostic Marker of Motor Progression in Parkinson’s Disease: A Systematic Review

M. Sabharwal, D. Dash, A. Elavarasi, (London, Canada)
Neurofilament Light Chain Triggers Protein Aggregation, Neurotoxicity and Gliosis in Parkinson’s Disease through p38/MK2/NF-κB/CREB1 and Nrf2/HO-1 Signalling

A. Nanda, RK. Singh (Lucknow, India)
Neuroimaging-guided automated optimization of deep brain stimulation in Parkinson’s disease: preliminary results

G. Imbalzano, C. Ledda, A. Romagnolo, M. Rizzone, L. Lopiano, M. Zibetti (Turin, Italy)
Neuroinflammation and neurodegeneration biomarkers in Parkinson’s disease: integration of neuroimaging and fluid markers

L. Melgarejo Martinez, S. Enriquez, A. Lopez, D. Samaniego, M. Miret, A. Laguna, M. Martinez, C. Lorenzo, J. Hernandez (Barcelona, Spain)
Neurological disease progression in adults with ataxia telangiectasia – a longitudinal study

AE. Hensiek, L. Bottolo, MY. Tiet, E. Harrison, H. Biggs, E. Ashby, C. Olympio, N. Everett, R. Horvath (Cambridge, United Kingdom)
Neurological Wilson’s disease: another form of tauopathies?

XP. Wang (Shanghai, China)
Neuromelanin Loss Is Associated with Increased Substantia Nigra Free-Water: a Longitudinal Study of Controls, RBD, and PD

V. Madge, K. Wennberg, R. Klevor, A. Dagher, R. Postuma, D L. Collins (Montréal, Canada)
Neuromelanin-Sensitive MRI as a Marker of Clinical Severity and Disease Burden in Parkinson’s Disease

R. Akande, T. Kustermann, S. Holiga, J. Anzures-Cabrera, G. Pagano (Basel, Switzerland)
Neuromodulation of Add-on Repetitive Transcranial Magnetic Stimulation improving Freezing of Gait in Parkinson’s Disease: Integrated Cross-sectional and Interventional Evidence

C. Gan, K. Zhang (Nanjing, China)
Neuronal aSynuclein Disease Integrated Staging System (NSD-ISS) Reveals Clinically Meaningful Functional Progression and Quality-of-Life Impact in Parkinson’s Disease

DA. Olszewska, D. Ghosh, S. Luo, C. Marras (Cork, Ireland)
Neurophysiologic Testing Aids Diagnosis of Stiff-person Spectrum Disorders

J. Bower, F. Ali, L. Jackson, B. Klassen, A. Zekeridou, A. Hassan (ROCHESTER, USA)
Neuroprotective and Antiparkinsonian Effects of Green-Synthesized Silver Nanoparticles from Eclipta prostrata in a Haloperidol-Induced Murine Model

S. Rajput, P. Tiwari, S. Sinha (Delhi, India)
Neuroprotective Effects of Curcumin on Hippocampal-PPN Circuitry in a Rotenone-Induced Rat Model of Parkinson’s Disease

L. Darbinyan, L. Hambardzumyan, L. Manukyan, M. Danielyan, K. Karapetyan, K. Simonyan (Yerevan, Armenia)
Neuroprotective Effects of Emodin Against Rotenone-Induced Parkinsonism Through Regulation of SIRT1-Mediated Inflammasome and Nrf2 Pathways

A. Kumar (Prayagraj, India)
Neuropsychiatric profile and its evolution in patients with Parkinson’s disease undergoing bilateral Subthalamic Deep Brain Stimulation – a retrospective study

H. S, S. Sachithanandan, D. P, A. Vijayaraghavan, S. Krishnan (Thiruvananthapuram, India)
Neuropsychiatric Symptom Changes in Parkinson’s Disease Patients Treated with Different Doses of Donepezil: A 24-Week Follow-up Study

EJ. Chung (Busan, Republic of Korea)
Neuropsychiatric Symptom Evolution Over the First Decade of Biomarker-Defined Parkinson’s Disease

I. Schoen, J. Wang, S. Xie, C. Caspell-Garcia, E. Mamikonyan, M. Stark, N. Dahodwala, A. Siderowf, R. Dobkin, M. York, D. Weintraub (Philadelphia, USA)
Neuropsychiatric Symptoms in Lewy Body Disease: Monoaminergic Activity and Resting State Networks

L. Wright, D. Burn, J. Taylor, J. O'Brien, A. Yarnall, M. Firbank, A. Thomas, R. Lawson (Newcastle, United Kingdom)
Neuropsychiatric Symptoms in Parkinson’s Disease in Low- and Middle-Income Countries: A Systematic Review

O. Uwishema (Kigali, Rwanda)
Neurotwain: Extended-reality based virtual brain imaging for one-stop-shop diagnosis and progression of Parkinson’s Disease

N. Hellmers, M. Mcmichael, G. Chiang, M. Sabuncu, S. Sichani, G. Cusimano, Z. Leng, H. Sarva, A. Goldan (New York, USA)
Nigrostriatal Dopaminergic Impairment Patterns in Idiopathic Normal Pressure Hydrocephalus Identified by 18F-FP-DTBZ PET: a 5-Year Longitudinal Study

C. Dong, N. Liu, JH. Ma, SY. Liu, P. Chan (Beijing, China)
Nigrostriatal Dopaminergic Patterns in Dementia with Lewy Bodies and Parkinson’s Disease Subtypes: A DAT-SPECT Study within the SOC Framework

G. Palermo, E. Bergamin, G. Bellini, G. Aghakhanyan, D. Frosini, V. Nicoletti, G. Tognoni, D. Volterrani, R. Ceravolo (Pisa, Italy)
NIH Multicenter Consortium for Gut-Brain Communication in Parkinson’s Disease: The Master Protocol and Timeline

T. Xie, C. Goetz, L. Becker, A. Bharucha, E. Chang, A. Keshavarzian, B. Kuo, L. Newby, K. Poston, L. Sanders, R. Savica, A. Sharma, A. Videnovic, L. Wruck (Chicago, USA)
Nine-Year Outcome of MRI Guided Focused Ultrasound Thalamotomy in Essential Tremor Patients

I. Schlesinger, M. Nassar, A. Sinai, I. Senderova, M. Katson, M. Constantinescu, M. Zaaroor, L. Lev Tov (Haifa, Israel)
NLRP3 Inhibition in Early-Stage Parkinson’s disease: Results of a Phase Ib Study

G. Pagano, B. Zinnhardt, N. Shariati, B. Ricci, M. Tagliati, A. Noyce, B. Bloem, H. Sarva, R. Kumar, K. Marek, K. Brockmann, T. Simuni, D. Standaert, N. Pavese, M. Politis, N. Milani Muelhardt, G. Kerchner, L. Kulic, A. Bonni (London, United Kingdom)
Nocturnal Blood Pressure Non-Dipping as an Autonomic Biomarker of Psychosis and Movement Disorder Severity in Pediatric Epilepsy

S. Sharma, V. Sharma, P. Maheshwari (Agra, India)
Nocturnal hypokinesia in Parkinson’s disease: impact on sleep and quality of life

I. Murasan, S. Diaconu, R. Ilea, R. Chiujdea, D. Batrinu, C. Falup-Pecurariu (Brasov, Romania)
Non-Motor Outcomes of Unilateral Magnetic Resonance-Guided Focused Ultrasound Surgery in Parkinson’s Disease: A Meta-Analysis

W. Kashif, K. Aung, S. Lane, T. Gilbertson, S. Khan, J. Osman-Farah, A. Macerollo (Liverpool, United Kingdom)
Non-Motor Phenotypes and Intestinal Microbiome Alterations in GBA1-Associated Parkinson’s Disease: Evidence for a Body-First Subtype

I. Miliukhina, E. Kryukova, S. Pchelina (Saint-Petersburg, Russian Federation)
Non-Motor Symptom Burden as a Key Determinant of Disease Clustering in Parkinson’s Disease

A. Rekik, R. Guizani, L. Bouafia, A. Mili, K. Jemai, H. Slimene, A. Hassine, S. Naija, S. Ben Amor (Sousse, Tunisia)
Non-Motor Symptom Improvement as a Driver of Quality of Life after Subthalamic Stimulation in Symmetric Parkinson’s Disease

ST. Jost, PA. Loehrer, K. Ashkan, A. Rizos, J. Krauss, E. Karst, A. Kosma, R. Biundo, J. Evans, V. Visser-Vandewalle, C. Nimsky, G. Fink, M. Silverdale, A. Fasano, P. Martinez-Martin, A. Antonini, P. Borghammer, L. Timmermann, K. Ray Chaudhuri, H. Dafsari (Cologne, Germany)
Non-Motor Symptoms in Hemifacial Spasm: A Cross-Sectional Study from a Brazilian Public Tertiary Center

M. Soares, M. Silva, JA. de Albuquerque, C. Franco, PA. Rocha Filho (Recife, Brazil)
Non-motor symptoms in Huntington’s disease: Results from the Validation of the Non-motor Symptoms Scale (MDS-NMS)

J. Valera-Bermejo, O. Makos, P. Eze, D. van Wamelen (London, United Kingdom)
Non-Rapid Eye Movement Sleep Neurophysiological Alterations in Lewy Body Disorders

J. Anderson, L. Churchill, A. Konuri, A. Ignatavicius, G. Cho, A. Lam, S. Naismith, R. Grunstein, S. Lewis, E. Matar (Camperdown, Australia)
Non‑Motor Outcomes after STN-FUS for Parkinson’s disease

E. Natera-Villalba, R. Rodríguez-Rojas, JA. Pineda-Pardo, T. Jimenez-Castellanos, M. Del Alamo, M. Escribano, D. Mata Marín, P. Guida, I. Obeso, JA. Obeso, R. Martínez-Fernández (Madrid, Spain)
Noninvasive Electrosonic Brain Stimulation for Parkinson’s Disease: Results from a Phase II Trial

F. Fregni, P. Teixeira, P. Gonzalez-Mego, A. Lepesteur Gianlorenco, C. Ramos-Estebanez, T. Wagner, L. Dipietro (Cambridge, USA)
Normal Pressure Hydrocephalus Imaging Markers in Movement Disorders: Comparison of Parkinson’s Disease, Essential Tremor, Dystonia, and Progressive Supranuclear Palsy

BC. Ari, I. Emekli, T. Yaz, A. Nazari, M. Basturk, N. Helvaci Yilmaz, Y. Samanci, A. Zirh, G. Kenangil (Istanbul, Turkey)
Normative Data for the IDEA Dementia Screen in Healthy Older Adults and People with Parkinson’s Disease in Ethiopia: A Comparative Cross Sectional Study

S. Gugssa, H. Kiflu, Y. Okkaoglu, G. Mengistu (Addis Ababa, Ethiopia)
Normative Dual-Task Gait Profiles Across the Adult Lifespan in Healthy Korean Adults

B. Jin, J. Kim, S. Cheon (Busan, Republic of Korea)
Novel associations of VPS13C with phenotype and conversion of idiopathic REM sleep behavior disorder

D. Ding, Z. Zhou, L. Liu (Shanghai, China)
Novel Modeling Approach for Comparing Treatment-Naive and Post-Treatment Neuronal Synucleinopathy Progression Using Multi-Modal PPMI Data

E. Brown, M. Kormaksson, Y. Chen, L. Chahine, S. Barker, C. Caspell-Garcia, J. Flores, M. Moscardo, A. Pethe, M. Azzarito, M. Pimenta Oliveira, A. Khanna, M. Niemi, P. Aarden, T. Simuni, K. Marek (San Francisco, USA)
Novel Presentation of Spinocerebellar Ataxia 27B (SCA27B): Episodic, Exercise-induced Truncal Dystonia Responsive to Dalfampridine

C. Donahue, M. Rochman, A. Dessy (Philadelphia, USA)
Novel Structural MRI-Based Progression Subtypes and Prognostic Study in Multiple System Atrophy

Y. Kang, J. Li, W. Md (Hangzhou, China)
NPC2 is an Allele-Specific Modifier of GBA1-Associated Parkinson’s Disease Risk

J. Kim, R. de Paula, C. Shaw, J. Shulman (Houston, USA)
Ntng2 Associated Neurodevelopmental Disorder A Recognisable Syndrome With Stereotypies

D. Türkmen, B. Aynekin, S. Ephytmiou, R. Maroofian, H. Per (Kayseri, Turkey)
Nutrition and Dietary Assessment as a Wellness Factor in Parkinson’s Disease and Related Disorders

N. Hellmers, B. Katz, M. Bruno, H. Sarva (New York, USA)
Nutritional Assessment in X-linked Dystonia Parkinsonism: Preliminary Results from a Pilot Study

PD. Lanuza, MM. Tabuzo-Acuin, FL. Libre, JM. Pascual, NK. Reyes, RD. Jamora (Manila, Philippines)
Nutritional Status as a Modifiable Determinant of Clinical Outcomes in Parkinson’s Disease: A 12-Month Longitudinal Study in Patients Treated with DBS and L-Dopa

N. Ayo Mentxakatorre, M. Acera Gil, C. Juanes-Moreno, T. Fernandez-Valle, B. Tijero, M. Ruiz-Lopez, JC. Gomez-Esteban, R. Del Pino (Barakaldo, Spain)
Nutritional Status Assessment in Patients with Parkinson’s Disease

MB. Charra Castellani, A. Silva, A. Gomez, M. Roldan, V. Kurtz, E. Knorre, D. Ballesteros (Buenos Aires, Argentina)
Nutritional status, clinical Features and lifestyle of Twins Discordant for Parkinson’s Disease

M. Barichella, A. Natale, E. Cereda, E. Contaldi, L. Magistrelli, C. Bolliri, M. Macchione, F. Invernizzi, D. Calandrella, I. Isaias, G. Pezzoli (Milano, Italy)

Jump to: View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z